MDMA (Ecstasy) and the Rave: A Review
Richard H. Schwartz, Norman S. Miller
Pediatrics October 1, 1997 DOI: 10.1542/peds.100.4.705 (opens in new tab)
Study at a glance
AI-extracted from the abstract| Characteristics | Peer reviewed |
|---|---|
| Topics | MDMA |
| Citations | 155 |
| Key points | The text describes MDMA as a "designer" drug increasingly used by American adolescents at raves and on college campuses, noting it is an amphetamine analogue with both stimulant and hallucinogenic properties. It states the drug has an undeserved reputation for safety and lists sweating, tachycardia, fatigue, and muscle spasms, including jaw-clenching, among common short-term adverse effects. |
Abstract
The drug 3,4 methylenedioxymethamphetamine (MDMA), also known as "ecstasy," is a "designer" drug that is becoming popular with American adolescents at dance halls known as "raves" and on college campuses. An analogue of amphetamine, MDMA shares properties with both amphetamine and hallucinogenic drugs. Now available in many US cities, MDMA has an undeserved reputation for safety and a long duration of action. The drug appeals to young people, who believe that it enhances empathy and closeness to others. Common short-term adverse effects of MDMA include sweating, tachycardia, fatigue, and muscle spasms, including jaw-clenching.
Citations in the library
Cited by 34
- Club drugs: methylenedioxymethamphetamine, flunitrazepam, ketamine hydrochloride, and gamma-hydroxybutyrate American Journal of Health-System Pharmacy June 1, 2002
- Death following ingestion of MDMA (ecstasy) and moclobemide Addiction February 20, 2003
- Pill content, dose and resulting plasma concentrations of 3,4‐methylendioxymethamphetamine (MDMA) in recreational ‘ecstasy’ users Addiction February 14, 2011
- Multiple MDMA (Ecstasy) Overdoses at a Rave Event Journal of Intensive Care Medicine May 28, 2012
- Ecstasy (MDMA) Deaths in New York City: A Case Series and Review of the Literature Journal of Forensic Sciences 2002
and 29 more in the library
Cites 15
- The molecular mechanism of "ecstasy" [3,4-methylenedioxy-methamphetamine (MDMA)]: serotonin transporters are targets for MDMA-induced serotonin release. Proceedings of the National Academy of Sciences March 1, 1992
- Subjective Reports of the Effects of MDMA in a Clinical Setting Journal of Psychoactive Drugs October 1, 1986
- Recreational MDMA use in Sydney: a profile of ‘Ecstasy’ users and their experiences with the drug British Journal of Addiction August 1, 1992
- 'Eve' and 'Ecstasy'. A report of five deaths associated with the use of MDEA and MDMA JAMA March 27, 1987
- (±3,4-Methylenedioxymethamphetamine Selectively Damages Central Serotonergic Neurons in Nonhuman Primates JAMA July 1, 1988
and 10 more in the library